Stress Management and Biological Age in Breast Cancer Patients.RCT
Psychological and Biological Outcomes in Breast Cancer Patients After Pythagorean Self-Awareness Intervention.
1 other identifier
interventional
60
1 country
1
Brief Summary
Intense stress has harmful effects on the body, contributing to various disorders. Breast cancer patients experience a build-up of stress due to their diagnosis and treatments. Stress can cause epigenetic changes in a cellular level (such as accelerated increase in biological age) that may negatively affect oncological treatments. This study aims to investigate the effect of stress management, specifically the Pythagorean Self-Awareness Intervention, on telomere length in T-leukocytes of breast cancer patients after completing all treatments except hormonal therapy. The study involves self-referred questionnaires, hair cortisol collection, and blood material extraction. Understanding the role of stress management in breast cancer may lead to improved patient outcomes and survival rates.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 4, 2021
CompletedFirst Submitted
Initial submission to the registry
July 23, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedAugust 9, 2023
August 1, 2023
2.7 years
July 23, 2023
August 2, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Psychological I
Perceived stress (measured by Perceived Stress Scale-14, expected decrease in mean score)
9 weeks after the 1st session
Psychological II
Symptoms of anxiety-stress-depression (measured by Depression Anxiety Stress Scale-21, expected decrease in mean scores)
9 weeks after the 1st session
Physical I
Telomere length (measured in mean T/S)
9 weeks after the 1st session
Physical II
Hair cortisol levels (measured in pg/mg )
9 weeks after the 1st session
Secondary Outcomes (2)
Physical III
9 weeks after the 1st session
Psychological III
9 weeks after the 1st session
Study Arms (2)
PSAI group
EXPERIMENTALParticipants are enrolled in the Pythagorean Self-Awareness Intervention (PSAI) where they receive weekly group sessions of 120 min for 8 weeks and they receive information about stress and lifestyle modifications and they are also instructed to practice the PSAI at bedtime and in the morning, every day, at home.
Control group
ACTIVE COMPARATOROne day seminar where they receive information about stress and lifestyle modifications
Interventions
The 8 sessions included biofeedback training in diaphragmatic breathing, information about distress, its symptoms, ways to manage stress through lifestyle modifications (physical activity, principals of Mediterranean diet without alcohol consumption, sleep hygiene, diaphragmatic breathing, conflict avoidance) \& instructions for lymphedema prevention, introduction to the Pythagorean Self-Awareness Intervention, instructions for the implementation of the technique, analysis of the Golden Verses,and their connection with lifestyle medicine as well as active involvement of the participants with group conversation and sharing of experiences.
The one day seminar included biofeedback training in diaphragmatic breathing, information about distress, its symptoms, ways to manage stress through lifestyle modifications (physical activity, principals of Mediterranean diet without alcohol consumption, sleep hygiene, diaphragmatic breathing, conflict avoidance) \& instructions for lymphedema prevention.
Eligibility Criteria
You may qualify if:
- Diagnosis of primary breast cancer
- Completion of anticancer therapy (except for hormonal therapy)
You may not qualify if:
- Psychiatric diagnosis and treatment
- Metastasis
- Previous participation in any stress management and health promotion study
- Inability to read or write in Greek
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Maria Charalampopouloulead
- Hippocration General Hospitalcollaborator
- Saint Savvas Anticancer Hospitalcollaborator
- Hellenic Anticancer Institutecollaborator
Study Sites (1)
Agios Savvas Hospital
Athens, 11522, Greece
Related Publications (5)
Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol. 2009 Jul;5(7):374-81. doi: 10.1038/nrendo.2009.106. Epub 2009 Jun 2.
PMID: 19488073BACKGROUNDLin Y, Wang C, Zhong Y, Huang X, Peng L, Shan G, Wang K, Sun Q. Striking life events associated with primary breast cancer susceptibility in women: a meta-analysis study. J Exp Clin Cancer Res. 2013 Aug 13;32(1):53. doi: 10.1186/1756-9966-32-53.
PMID: 23941600BACKGROUNDDamjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B, Zou Y, Beversdorf DQ, Weng NP. Accelerated telomere erosion is associated with a declining immune function of caregivers of Alzheimer's disease patients. J Immunol. 2007 Sep 15;179(6):4249-54. doi: 10.4049/jimmunol.179.6.4249.
PMID: 17785865BACKGROUNDCharalampopoulou M, Bacopoulou F, Syrigos KN, Filopoulos E, Chrousos GP, Darviri C. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial. Breast. 2020 Feb;49:210-218. doi: 10.1016/j.breast.2019.12.012. Epub 2019 Dec 20.
PMID: 31901782BACKGROUNDCarlson LE, Beattie TL, Giese-Davis J, Faris P, Tamagawa R, Fick LJ, Degelman ES, Speca M. Mindfulness-based cancer recovery and supportive-expressive therapy maintain telomere length relative to controls in distressed breast cancer survivors. Cancer. 2015 Feb 1;121(3):476-84. doi: 10.1002/cncr.29063. Epub 2014 Nov 3.
PMID: 25367403BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Flora Bacopoulou, MD,PhD
Aghia Sofia Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- PhD candidate
Study Record Dates
First Submitted
July 23, 2023
First Posted
August 9, 2023
Study Start
January 4, 2021
Primary Completion
October 1, 2023
Study Completion
January 1, 2024
Last Updated
August 9, 2023
Record last verified: 2023-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- After publication of the study
- Access Criteria
- On request
All IPD that underlie results in a publication